Additionally, the PD+pRBD cohort notably behaves differently (e.g., the LRRK2 and MAPT loci) compared to the published PD GWAS22, which includes both PD with and without RBD, suggesting the subset of PD patients who have RBD may be genetically distinct. This evidence concerns the gene MAPT and Parkinson disease.